NEW YORK (GenomeWeb) – OpGen said today that it has closed its previously announced $10 million public offering consisting of more than 18 million units of common stock at $.40 per unit and about 6.8 million prefunded units at $.39 per unit.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.
This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.
This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.